BAFF ligand-based CAR-T cells have shown effectiveness in killing cells from various B-cell malignancies, including ALL, mantle cell lymphoma (MCL), and MM cells both in vitro and in vivo [77, 78]. The gene discussed is TNFSF13B; the disease is acute lymphoblastic leukemia.